Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Observation of Three Dimensional Conformal Radiotherapy with Tamoxifen in Treatment of Postoperative Malignant Glioma

  • Zhou, Shao-Bing (Department of Radiation Oncology, Affiliated People's Hospital of Yangzhou University) ;
  • Liu, Yang-Chen (Department of Radiation Oncology, Affiliated People's Hospital of Yangzhou University) ;
  • Yin, Xiao-Xiang (Department of Radiation Oncology, Affiliated People's Hospital of Yangzhou University) ;
  • Ding, Wen-Xiu (Department of Radiation Oncology, Affiliated People's Hospital of Yangzhou University) ;
  • Guo, Xin-Wei (Department of Radiation Oncology, Affiliated People's Hospital of Yangzhou University) ;
  • Gu, Liang (Department of Radiation Oncology, Affiliated People's Hospital of Yangzhou University) ;
  • Huang, Xin-En (Department of Chemotherapy, the Affiliated Jiangsu Cancer Hospital of Nanjing Medical University and Jiangsu Institute of Cancer Research)
  • Published : 2015.03.18
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: To evaluate the efficacy and adverse effects of three dimensional conformal radiotherapy (3D-CRT) with tamoxifen in treating patients with postoperative malignant glioma. Patients and Methods: 60 patients of postoperative malignant glioma were randomly assigned into two groups, 30 patients were treated with 3D-CRT plus tamoxifen (treatment group), and the other 30 patients with 3D-CRT plus temozolomide (control group). All patients were radiated by 6MV X-ray, 2.0Gy per fraction, once daily, with a total dose (DT) of 56~60Gy. Tamoxifen was delivered at $60mg/m^2/d$, temozolomide was given at $75mg/m^2/d$. All patients were treated with concurrent radiotherapy. Results: One, 2, 3 year survival rates of treatment and control group were 63.3%, 30.0%, 23.0% and 70.0%, 33.3%, 26.7%, respectively (${\chi}^2=0.01$, 0.23, 0.09, P>0.05). The rate of thromboembolism in treatment group was 6.7%. Conclusion: Therapeutic efficacy of two groups was similar, but it was more cost-effective in treatment group, and toxicity did not increase.

Keywords

References

  1. Broniscer A, Leite CC, Lanchote, et al (2000). Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. J Clin Oncol, 18, 1246-53.
  2. Flannery TW, Dibiase S, Patel S, et al (2005). A Phase I clinical trial assessing temozolomide and tamoxifen with concomitant radiotherapy for the treatment high-grade gliomas. Int J Radiat Oncol Biol Phys, 82, 739-42.
  3. Liu XX, Cui L, Dong HM (2009). Clinical observation in 3 dimensional conformal radiotherapy (3D-CRT) concurrent chemotherapy in treatment of postoperative cerebral gliomas. China Oncology, 12, 938-42.
  4. Partap S, Fisher PC (2007). Update on new treatments and developments in childhood brain tumors. Curt Opin Pediart, 19, 670-4. https://doi.org/10.1097/MOP.0b013e3282f0eafa
  5. Pashaki AS, Hamed EA, Mohamadian K, et al (2014). Efficacy of high dose radiotherapy in post-operative treatment of glioblastoma multiform--a single institution report. Asian Pac J Cancer Prev, 15, 2793-6. https://doi.org/10.7314/APJCP.2014.15.6.2793
  6. Pollack IF, DaRosso RC, Robertson PL, et al (1997). A phase I study of high-dose tamoxifen for the treatment of refractory malignant gliomas of childhood. Clin Cancer Res, 3, 1109-15.
  7. Robins H, Won M, Seiferheld WF, et al (2006 ). Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme. Neuro oncolo, 8, 47-52. https://doi.org/10.1215/S1522851705000311
  8. Tang Xi, Hu Ya, Xu Yanhua (2009). Clinical research in three-dimensional conformal radiotherapy combined with Temozolomide in the treatment of malignant glioma. Prog Modern Biomedicine, 12, 2885-6.
  9. Tian DS, Liu JL, Xie MJ, et al (2009). Tamoxifen attenuates inflammatory-mediated damage and improves functional outcome after spinal cord injury in rats. J Neurochem, 109, 1658-67. https://doi.org/10.1111/j.1471-4159.2009.06077.x
  10. Wang JJ, Wang G, Du SM, et al (2013). Relations between multidrug resistance and P13K/Akt signaling pathway and treatment progression of glioma. Oncology Progress, 11, 287-91.
  11. Wang LY, Tu QS, Zhou WB, et al (2011). Efficacy and safety of 3-dimensional conformal radiotherapy combined with Temozolomide for glioma. J Central South University, 4, 1106-10.
  12. Yin WB, Yu ZH, Xu GZ, et al (2008). Beijing: Beijing union medical university press, Radiation Oncology, 1122-9.
  13. Zhang W, Couldwell WT, Song H, et al (2000). Tamoxifeninduced enhancement of calcium signaling in glioma and MCF-7 breast cancer cells. Cancer Res, 60, 395-400.
  14. Zheng W, Nie Q, Kang JB, et al (2011). Clinical efficacy study of concurrent chemoradiotherapy for patients with postoperative high grade glioma. Chinese J Neuromedicine, 10, 900-4.

Cited by

  1. Safety and Efficacy of a Mouth-Rinse with Granulocyte Colony Stimulating Factor in Patients with Chemotherapy-Induced Oral Mucositis vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.413
  2. A Clinical Study on Juheli (Recombinant Human Interleukin - 11) in the Second Prevention of Chemotherapy Induced Thrombocytopenia vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.485